SSSuja Rani Sasidharan

Suja Rani Sasidharan

*This is an algorithmically generated author record based on publicly available information.

Suja Rani Sasidharan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Acute dermal toxicity evaluation of eugenol-incorporated hydrogel in Sprague Dawley rats

    by Pooja Krishna Kizhekku Veettil, Suja Rani Sasidharan, Nisha Ayinikkattil Ravindran, Preethy John, Anoopraj Rajappan, Reji Varghese

    Background: Multidrug-resistant Staphylococcus aureus (MDRSA) infections significantly impair wound healing, often leading to chronic wounds and systemic complications. There is a need for wound dressings that are not only antibacterial but also biocompatible. Essential oils, such as eugenol, possess potent antibacterial properties, but their direct application is limited by volatility and instability. Incorporating eugenol into a polymeric hydrogel provides a stable delivery system, while ensuring safety prior to in vivo use is essential. Objectives: This study aimed to evaluate the dermal safety of eugenol-incorporated chitosan-PVA hydrogel (Eug-CH) in Sprague Dawley rats, following OECD Test Guideline 402. Materials and Methods: The inert chitosan-PVA hydrogel was synthesised via chemical crosslinking, followed by incorporation of eugenol as an emulsion. Acute dermal toxicity testing was conducted according to OECD 402, with topical application to the dorsal skin under semi-occlusive conditions. Sequential doses up to 2000 mg/kg were administered, with a total of five female rats used. Animals were monitored intensively for 24 h post-application and daily for 14 days, assessing dermal integrity, behaviour and systemic signs of toxicity. Results: Topical application of Eug-CH produced no mortality or toxicity at doses up to the tested limit dose of 2000 mg/kg. Observations over 14 days revealed no adverse effects, including erythema, edema, tremors, convulsions, or behavioural abnormalities. Gross necropsy showed no organ abnormalities and a normal increase in body weight was noted. These findings indicate that the Eug-CH formulation is safe for dermal application in rats even upto the limit dose level. Conclusion: The Eug-CH hydrogel showed no mortality, skin irritation or pathological changes at doses ranging from 200 to 2000 mg/kg, with normal body weight gain observed over 14 days. With an LD₅₀ exceeding 2000 mg/kg, the formulation is classified as GHS Category 5 (low hazard), confirming its safety for regulatory purposes. These results indicate that the eugenol incorporated hydrogel is highly biocompatible and suitable as an antibacterial wound dressing without risk of dermal toxicity.

  • Open Access

    Protective Effect of Lemon Grass Oil and Citral on Amelioration of Cadmium-induced Nephrotoxicity and Hepatotoxicity

    by Sona Shaji, Rani S. Suja, Anoop Raj, Sujith Samraj

    The experiment was conducted during January to May, 2025 at Department of Veterinary Pharmacology and Toxicology, at College of Veterinary and Animal Sciences, Mannuthy, Kerala, India to study the potential nephro- and hepatoprotective effects of lemongrass oil (LGO) and its active constitutent, citral against cadmium (Cd) induced renal and hepato damage. Thirty-six adult male Sprague Dawley (SD) rats weighing 150–200 g were kept in well-ventilated polypropylene cages under standard laboratory conditions of 12 h/12 h light/dark cycle at 25°C±2°C with 30–70% relative humidity. The experimental rats were divided into six groups of six animals each. Group I received 0.1% Tween 80 and normal saline, and group II received both cadmium chloride (7 mg kg-1 b.wt.) and Tween 80, while groups III to VI received LGO and citral at 45 and 90 mg kg-1 body weight dose levels, respectively, as oral administration for 28 days, along with cadmium chloride treatment. Significantly elevated serum markers of renal and hepatic dysfunction, alongside the altered oxidative stress indicators, were restored in the present study with LGO and citral treatment. Histological examination further confirmed that LGO and citral at both dose levels attenuated Cd-induced structural damage in kidney and liver tissues. Thus, the results were indicative of significant nephroprotective and hepatoprotective potentials of citral and LGO on Cd-induced nephro- and hepatotoxicity, which might be attributed to its antioxidant activity.

  • Phytochemical based nanoformulations: an advanced strategy for the management of metabolic syndrome

    by S Sudhakar, Suja Rani S

    Metabolic syndrome (MetS), a silent epidemic condition is characterized by a cluster of metabolic dysfunctions, including hypertension, central obesity, insulin resistance and atherogenic dyslipidemia, which collectively increase the risk of type 2 diabetes mellitus and cardiovascular diseases. The rising global prevalence of MetS and its association with increased morbidity and mortality have made it a significant public health concern. The complex pathophysiology of MetS, driven by the intricate interplay of metabolic, hormonal and inflammatory pathways, often results in partial therapeutic efficacy, treatment resistance and challenges in achieving sustained disease control. Recently, phytochemicals which are the bioactive compounds derived from plants have gained considerable attention for their therapeutic potential in managing MetS owing to their diverse pharmacological properties, such as anti-inflammatory, antioxidant and hypoglycemic effects. Phytochemicals like curcumin, resveratrol and epigallocatechin gallate have demonstrated efficacy in ameliorating metabolic derangements associated with MetS. However, their clinical application is often limited by poor bioavailability, rapid metabolism and low solubility. To address these limitations, nanoformulations of phytochemicals have been developed, leveraging advancements in nanotechnology to enhance their stability, solubility and bioavailability. Encapsulation in nanosystems, such as liposomes, polymeric nanoparticles, nanoemulsions and solid lipid nanoparticles, enables sustained release, targeted delivery and improved therapeutic efficacy while minimizing adverse effects. These nanoformulations facilitate precise delivery of active moieties to specific tissues or cellular targets, thereby optimizing therapeutic outcomes. This review highlights the potential of application of nanoformulated phytochemicals in the management of MetS, emphasizing their pharmacokinetic improvements and therapeutic benefits.


  • Evaluation of acute oral toxicity of lemon grass oil and citral in albino rats

    by Adheena Xavier, S Suja Rani, R Shankar, Ar Nisha, S Sujith, R Uma

    Essential oils, which are the plant derived secondary metabolites have been reported for various traditional medicinal applications. Amongst them, lemongrass oil (LGO) derived from Cymbopogon spp. as well as its major constituent citral possess a myriad of therapeutic potentials. The present study has been undertaken to study the adverse effects of LGO and citral on acute oral exposure to Sprague Dawley rats to establish the preliminary safety of these compounds prior to their efficacy evaluation against fatty liver disease. The toxicity study was conducted as per OECD guidelines No. 420. The LGO and citral were solubilized in 1% tween 80 and administered orally in a sequential manner in one animal at 2000 mg/kg (sighting study) followed by four animals (main study). The animals were then monitored for any clinical abnormalities or mortality and body weight gain during the observational period of 14- days, after which the animals were sacrificed and examined for abnormal lesions. LGO was further subjected to gas chromatography-mass spectrometry (GC-MS) analysis to characterize its chemical constituents, which revealed alpha and beta citral as the two major constituents. The rats treated with LGO and citral survived throughout the study period and didn’t exhibit any clinical abnormalities. Moreover, body weight gain was comparable to the vehicle treated rats and necropsy revealed no pathological alterations. Thus, the present study indicated LGO and citral as safe compounds with an LD50 greater than 2000 mg/kg and could be labelled as category 5/unclassified in hazard category of Globally harmonized system for classification of chemicals.